Article
PDGF receptor signaling networks in normal and cancer cells
22 Mar 2014
Abstract excerpt
For about four decades, platelet-derived growth factors (PDGF) and their receptors have been the subject of intense research, revealing their roles in embryo development and human diseases. Drugs such as imatinib, which selectively inhibit the tyrosine kinase activity of these receptors, have been approved for the treatment of cancers such as gastrointestinal stromal tumors and chronic eosinophilic leukemia....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
